Quick Takeaways
- HBM Healthcare Investments (Cayman) Ltd. filed SCHEDULE 13G for Upstream Bio, Inc. Common Stock, par value $0.001 per share (UPB).
- Disclosed ownership: 5.1%.
- Date of event: 31 Dec 2024.
HBM Healthcare Investments (Cayman) Ltd. - 31 Dec 2024 SCHEDULE 13G Report for Upstream Bio, Inc. Common Stock, par value $0.001 per share (UPB)
- Filing Manager
- HBM Healthcare Investments (Cayman) Ltd.
- Reporting Manager
- HBM Healthcare Investments (Cayman) Ltd.
- Symbol
- UPB
- Shares outstanding
- 53,236,392 shares
- Disclosed Ownership
- 2,715,056 shares
- Ownership
- 5.1%
- Form type
- SCHEDULE 13G
- Filing time
- 13 Feb 2025, 16:16:17 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 14 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"HBM Healthcare Investments (Cayman) Ltd. disclosed 5.1% ownership in Upstream Bio, Inc. Common Stock, par value $0.001 per share (UPB) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Feb 2025, 16:16.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| HBM Healthcare Investments (Cayman) Ltd. | 5.1% | 2,715,056 | 2,715,056 | 0 | /s/ Jean-Marc LeSieur | Jean-Marc LeSieur, Managing Director |